GeroScience
Scope & Guideline
Transforming Insights into Aging Solutions
Introduction
Aims and Scopes
- Mechanisms of Aging:
This journal explores the cellular and molecular mechanisms that contribute to aging, including oxidative stress, cellular senescence, and changes in mitochondrial function. - Aging and Disease Correlation:
It investigates the relationship between aging and various diseases, particularly neurodegenerative disorders, cardiovascular diseases, and metabolic syndromes. - Interventions for Healthy Aging:
The journal publishes studies on interventions aimed at promoting healthy aging, including pharmacological treatments, dietary modifications, and lifestyle changes. - Biomarkers of Aging:
Research on identifying and validating biomarkers that indicate biological age, frailty, and the risk of age-related diseases is a key focus. - Translational Research:
GeroScience emphasizes translational studies that bridge laboratory findings with clinical applications to improve health outcomes in aging populations. - Animal Models of Aging:
Utilizing animal models, including mice, dogs, and non-human primates, to study aging processes and test potential therapeutic interventions is a significant aspect of the journal's research.
Trending and Emerging
- Interdisciplinary Approaches to Aging:
There is a growing trend towards integrating insights from various disciplines, including genetics, neuroscience, and social sciences, to create a more comprehensive understanding of aging. - Focus on Frailty and Functional Decline:
Research increasingly centers on frailty as a crucial indicator of health status in older adults, emphasizing the need for interventions that enhance functional capacity and quality of life. - Microbiome and Aging:
Studies exploring the relationship between the gut microbiome and aging are gaining prominence, highlighting the microbiome's role in healthspan and disease susceptibility. - Innovative Therapeutics and Senolytics:
There is a trend towards investigating novel therapeutics, particularly senolytics, which target cellular senescence to mitigate age-related health decline. - Personalized Medicine in Aging:
The emergence of personalized and precision medicine approaches tailored to individual aging profiles and genetic backgrounds is becoming a significant focus. - Neuroinflammation and Cognitive Aging:
Research on the role of neuroinflammation in cognitive decline and neurodegenerative diseases is increasingly prevalent, reflecting an understanding of the complex interplay between aging and brain health.
Declining or Waning
- Traditional Anti-Aging Therapies:
Research focusing on traditional anti-aging therapies, such as hormone replacement or simple dietary supplements, has seen a decline as more nuanced and mechanistic approaches gain traction. - Single-Factor Studies:
There is a noticeable decrease in studies that examine a single factor in isolation without considering the complex interactions involved in aging and health. - Epidemiological Studies without Mechanistic Insights:
While epidemiological studies are important, there is a waning interest in those that do not link findings to underlying biological mechanisms or therapeutic implications. - Animal Models with Limited Relevance to Humans:
Research utilizing animal models that do not effectively translate to human aging processes or health outcomes is becoming less common. - Emerging Technologies in Isolation:
The focus on emerging technologies such as artificial intelligence or big data analytics without integrating them into broader aging research frameworks is declining.
Similar Journals
Neuropeptides
Fostering Collaboration in Cellular and Molecular NeuroscienceNeuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.
REJUVENATION RESEARCH
Pioneering Research for a Healthier TomorrowRejuvenation Research is a premier journal dedicated to the advancing field of gerontology and aging research, published by Mary Ann Liebert, Inc. Established in 2000, the journal serves as a pivotal platform for the dissemination of scholarly articles that explore the complex mechanisms of aging and innovative approaches to rejuvenation. With an impact factor reflective of its robust scholarly contributions, the journal currently holds a Q4 ranking in Aging and a Q3 ranking in Geriatrics and Gerontology, showcasing its relevance in the academic community. This periodic publication, welcoming open access submissions, invites researchers, professionals, and students alike to engage with cutting-edge findings that could shape future geriatric practices and enhance quality of life. The journal underscores the importance of interdisciplinary collaboration, encouraging explorations that intersect with biochemistry, genetics, and other vital areas of study. Through its ongoing commitment to high-quality research, Rejuvenation Research remains a critical resource for understanding the biological underpinnings of aging and the strategies to mitigate its effects.
FREE RADICAL BIOLOGY AND MEDICINE
Exploring the Dynamics of Free Radicals in Health and DiseaseFREE RADICAL BIOLOGY AND MEDICINE, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and medical physiology. With an ISSN of 0891-5849 and an E-ISSN of 1873-4596, this journal stands out with its impressive ranking in the 2023 category quartiles: Q1 in Biochemistry and Q1 in Physiology (medical). Specifically, it has achieved a remarkable position of 29th out of 438 in Biochemistry and 8th out of 113 in Physiology, placing it firmly in the 93rd percentile of its field, as per Scopus rankings. Since its inception in 1987, the journal has focused on advancing the understanding of free radicals and their role in biological processes, encompassing a wide range of topics from oxidative stress to therapeutic applications. Although it does not currently offer open access, the journal's rigorous peer-review process and impactful research ensure that it remains a valuable resource for researchers and professionals seeking to explore the intricate relationships between free radicals and health. The journal's headquarters are located at STE 800, 230 Park Ave, New York, NY 10169, reflecting its esteemed place within the scientific community and commitment to high-quality research.
Aging-US
Unveiling the Mysteries of Longevity and HealthAging-US is a premier peer-reviewed journal dedicated to advancing the field of aging research and cell biology. Published by IMPACT JOURNALS LLC, this journal serves as a vital resource for researchers and professionals exploring the biological mechanisms of aging and their implications for health and disease. With a commendable impact factor reflected in its 2023 Scopus rankings, where it stands at Rank #10/38 in the category of Aging and Rank #63/285 in Cell Biology, Aging-US exemplifies rigorous scientific excellence. Its open access policy enhances accessibility, fostering a wider dissemination of knowledge in both academic and clinical settings. Spanning from 2009 to 2024, the journal provides a platform for groundbreaking studies and innovative methodologies, ensuring that it remains at the forefront of the dynamic conversations surrounding aging and cellular biology. Engage with Aging-US to contribute to the evolving narratives of longevity and cellular health.
MECHANISMS OF AGEING AND DEVELOPMENT
Decoding the Secrets of Life's ProgressionMECHANISMS OF AGEING AND DEVELOPMENT is a premier academic journal published by Elsevier Ireland Ltd, specializing in the fields of aging and developmental biology. With an impressive Q1 ranking in both categories as of 2023, this journal serves as a vital platform for researchers, professionals, and students seeking to advance their understanding of the complex biological processes that underlie aging and development. Since its inception in 1972, the journal has steadily contributed to the accumulation of valuable knowledge, maintaining a history of rigorous peer-reviewed articles that explore genetic, molecular, and cellular mechanisms impacting aging and development. Its high Scopus rankings—notably 5th in Aging and 8th in Developmental Biology—underscore its significance in the scientific community. While the journal follows a traditional publishing route without Open Access options, it remains an indispensable resource for those dedicated to the investigation of life’s aging processes and developmental phenomena. With publication projected through to 2024, the MECHANISMS OF AGEING AND DEVELOPMENT continues to shape the discourse within these critical research domains.
Frontiers in Aging
Fostering Multidisciplinary Dialogues on AgingFrontiers in Aging is a leading academic journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the biological processes associated with aging. Established in 2020, this open-access journal aims to bridge the gap between various disciplines including genetics, molecular biology, and physiology, providing a multidisciplinary platform for researchers and clinicians alike. With a notable impact factor denoted by its Q2 quartile rankings in Aging, Genetics, and Molecular Biology, and a Q1 ranking in Physiology as of 2023, the journal is recognized for its contribution to the scientific community. Located in Lausanne, Switzerland, it is committed to promoting open discourse and publishing cutting-edge studies that address the complexities of aging and its implications for health and longevity. The journal’s editorial board, consisting of leading experts, ensures the rigorous peer-review process, maintaining high academic standards and fostering innovation in aging research.
AGING CELL
Connecting Global Minds in Aging ResearchAGING CELL is a premier peer-reviewed journal published by Wiley, specializing in the rapidly evolving field of aging research and cell biology. Established in 2002 and enjoying an impressive track record as evidenced by its Q1 ranking in both Aging and Cell Biology categories for 2023, the journal has become a vital resource for researchers and professionals alike. With a significant impact factor highlighting its scholarly influence, AGING CELL offers an open access model since 2014, ensuring that groundbreaking research is accessible to the global community. The journal covers a wide array of topics related to the mechanisms of aging at the cellular and molecular levels, making it essential reading for anyone invested in understanding the complexities of aging processes and their implications for health and disease. With a broad international readership based in the United Kingdom and beyond, AGING CELL is dedicated to disseminating high-quality research that impacts scientific understanding and fosters advances in the field.
npj Aging and Mechanisms of Disease
Connecting Research to Transform Aging Sciencenpj Aging and Mechanisms of Disease is a leading open-access journal dedicated to advancing the understanding of the biological mechanisms underlying aging and age-related diseases. Published by NATURE PORTFOLIO in the United Kingdom, this journal has established itself as a vital resource within the fields of Aging and Geriatrics and Gerontology, proudly holding a prestigious Q1 ranking in both categories as of 2023. With an impressive Scopus ranking, placing it in the top 10 for Geriatrics and Gerontology, and the top 9 for Aging, the journal is committed to disseminating high-quality, peer-reviewed research that offers innovative insights and fosters collaboration among researchers and practitioners. Since its inception in 2015, npj Aging and Mechanisms of Disease has embraced the open-access model, ensuring that groundbreaking findings are freely available to all, thereby promoting widespread knowledge-sharing within the scientific community. This journal serves as an essential platform for those seeking to explore the complex interplay of genetic, molecular, and environmental factors that influence aging and its associated challenges.
Aging Brain
Pioneering Insights into the Aging ProcessAging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.
Aging and Disease
Exploring the intersection of longevity and health.Aging and Disease is a leading open-access journal published by the International Society on Aging and Disease, dedicated to advancing the understanding of aging and its associated diseases. Since its inception in 2010, the journal has established itself as a vital resource for researchers and practitioners in the fields of Geriatrics, Neurology, Cell Biology, and Pathology. With an impressive Q1 ranking across multiple categories and a robust position in Scopus rankings, including ranks in the top 3% in Geriatrics and Gerontology, it showcases high-quality research that addresses the complexities of aging processes. Each issue presents original articles, reviews, and insights aimed at improving health outcomes for the aging population. The open-access model ensures that valuable research findings are readily available to a global audience, fostering collaboration and innovation. As a go-to publication for scholars, healthcare professionals, and students, Aging and Disease significantly contributes to the multidisciplinary dialogue surrounding aging and its health implications.